GESTIÓN EN SALUD PÚBLICA: Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers Guidance for Industry | FDA

jueves, 9 de septiembre de 2021

Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers Guidance for Industry | FDA

Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers Guidance for Industry | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)